Society for Clinical Research Sites Announces New Site Advocacy Groups

April 22, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

Since its inception in early 2014, the SAG initiative has exercised considerable impact on the clinical research landscape by inciting important dialogue between site professionals and industry leaders related to current and evolving practices.

The Society for Clinical Research Sites, the global trade organization dedicated to representing the interests of clinical research sites, today announced new developments to its landmark Site Advocacy Group initiative. The Site Advocacy Group (SAG) initiative enables clinical investigators and site professionals to interact directly with senior industry leaders in the exchange of perspectives and experiences on innovative ideas, processes, tools, and technologies.

Since its inception in early 2014, the SAG initiative has exercised considerable impact on the clinical research landscape by inciting important dialogue between site professionals and industry leaders related to current and evolving practices.